Construction nearly complete on new injectables plant in Memphis

Construction on a new, $20 million injectables plant in Memphis, Tennessee, is wrapping up.

Construction of the $20 million Plough Center for Sterile Drug Delivery Systems in Memphis, Tennessee, is expected to be completed in the coming weeks.

The 10,000-square-foot injectables facility will be operated by the University of Tennessee Health Science Center (UTHSC) and is located in the Memphis Medical District. It’s expected to employ about 20 people and will be able to produce 50,000 vials per day, or 100,000 to 200,000 syringes, the Daily News in Memphis reported.

The facility is expected to open by the end of the year and will manufacture only liquid medications for injectables.

“It will enhance some of the work the college of pharmacy and the pharmaceutical scientists do to get new drugs to market,” Dr. Kennard Brown, UTHSC executive vice chancellor and CEO, told the Daily News.

Suggested Articles

GBA offers Brexit escape, Merck and Just - Evotech to share production space, GSK ointment line in Bangladesh may reopen and more news of note.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.